Agilent Technologies Ships 10,000th 5975 Series GC/MS
December 17, 2008
SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE:A - News) today announced it has delivered the 10,000th unit of its 5975 Series gas chromatograph/mass spectrometer (GC/MS). Introduced just over three years ago, the Agilent 5975 Series is well on its way to becoming the most popular GC/MS of all time. “The only thing we can say to [...]
December 17, 2008
A Global Biopharmaceutical Company Purchases Two PCT Systems to Help in the Analysis of Therapeutic Proteins SOUTH EASTON, Mass., Dec. 17 -- Pressure BioSciences, Inc. (Nasdaq: PBIO) ("PBI") today announced that they have entered into a collaboration with the J. Craig Venter Institute ("JCVI"), a not for profit genomic research institute, with facilities in Rockville, [...]
Emory University Purchases Corning® Epic® System
December 17, 2008
Corning Incorporated (NYSE: GLW) today announced that Emory University purchased the label-free Corning® Epic® System to integrate into its extensive drug discovery program at the Emory Chemical Biology Discovery Center (ECBDC). This technology will enable ECBDC to further develop chemical tools for biological research and drive the discovery of new drug compounds which may lead [...]
AnaSpec Introduces Industry’s First Fluorimetric Assay Kit for Aggrecanase-1 Activity Detection
December 17, 2008
San Jose, CA, December 17, 2008 --(PR.com)-- AnaSpec has announced the release of the industry’s first fluorimetric assay optimized to detect ADAMTS-4 (aggrecanase-1) activity - the SensoLyteTM 520 Aggrecanase-1 Assay Kit. A FRET based assay, it is homogeneous and has an emission in the green range (Ex/Em= 490 nm/520 nm). The kit contains a novel [...]
December 17, 2008
Comprehensive Rheology Solutions RHEOLOGIC and Smart RHEO are the most technically advanced laboratory capillary rheometers on the market for the determination of the flow behavior of a wide range of materials. Both floor and bench top models are available with singe and dual bore capabilities. The computer controlled instruments offer testing abilities to measure shear [...]
SeraCare to Sell RayBiotech Proteomic Products Worldwide
December 17, 2008
SeraCare Life Sciences, Inc. (NASDAQ: SRLS) and RayBiotech, Inc. announced today that SeraCare will act as an agent for the sale of RayBiotech's full product line of antibody arrays, protein arrays, tissue microarrays and ELISA and EIA kits. The synergy of RayBiotech's innovative portfolio with SeraCare's global reach and expertise in virology, serology, immunology and [...]
Cetero Research Continues Growth in Bioanalytical Service Offerings
December 17, 2008
Cetero Research, an industry leader in clinical pharmacology, bioanalytical and specialty Phase II-IV services, announces strategic expansions in its bioanalytical operations. Cetero now has a fully operational immunochemistry group in Houston, and its Toronto bioanalytical laboratory has added the newest AB Sciex Triple QuadTM 5500 system. “Our new immunochemistry laboratory is a state-of-the-art laboratory for [...]
Seegene Awarded Patent for Haplotyping Using Multiplex PCR
December 17, 2008
Seegene, Inc., a leader in multi-pathogen diagnostic testing, today announced that it has been awarded international patent protection for a break-through technology able to accelerate the detection of highly personal variations in genetic sequences. These genetic variations can identify an individual's risks for a broad range of disorders, such as Alzheimer's disease and coronary artery [...]
Implant Sciences Completes $5.6 Million Financing
December 16, 2008
Laurus and Bridge Bank Obligations Retired in Connection with Financing WAKEFIELD, Mass.--Implant Sciences Corporation (NYSE Alternext US: IMX), a supplier of sophisticated systems and sensors for the homeland security market and related industries, today announced the execution of a Note and Warrant Purchase Agreement with DMRJ Group, LLC on December 10, 2008. DMRJ Group, LLC [...]
CombiMatrix Launches New Prostate Cancer Array-Based Diagnostic Test
December 16, 2008
ProScan Array is First Genome-Based Test to Introduce Genomic Pathology to Prostate Cancer MUKILTEO, Wash., Dec 16, 2008 -- CombiMatrix Corporation today announced the introduction of the first prostate cancer array-based test. Known as the ProScan(tm) test, it complements the company's growing portfolio of array-based diagnostic tests. The ProScan test is based on key peer-reviewed [...]

